A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

PHASE2TerminatedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

February 9, 2024

Study Completion Date

May 23, 2024

Conditions
Congenital Adrenal Hyperplasia
Interventions
DRUG

Tildacerfont/Placebo

Tablet, administered daily

Trial Locations (65)

6009

Spruce Study Site, Nedlands

19104

Spruce Study Site, Philadelphia

19107

Spruce Study Site, Philadelphia

21287

Spruce Study Site, Baltimore

28203

Spruce Study Site, Columbia

28601

Spruce Study Site, Hickory

33401

Spruce Study Site, West Palm Beach

33612

Spruce Clinical Site, Tampa

35294

Spruce Study Site, Birmingham

38163

Spruce Clinical Site, Memphis

43210

Spruce Study Site, Columbus

44195

Spruce Study Site, Cleveland

44718

Spruce Study Site, Canton

45219

Spruce Study Site, Cincinnati

46202

Spruce Clinical Site, Indianapolis

55454

Spruce Clinical Site, Minneapolis

55905

Spruce Study Site, Rochester

60611

Spruce Study Site, Chicago

75093

Spruce Study Site, Dallas

76104

Spruce Clinical Site, Fort Worth

78539

Spruce Clinical Site, Edinburg

78731

Spruce Study Site, Austin

80113

Spruce Study Site, Englewood

89148

Spruce Clinical Site, Las Vegas

90027

Spruce Study Site, Los Angeles

92868

Spruce Clinical Site, Orange

95817

Spruce Study Site, Sacramento

97702

Spruce Clinical Site, Bend

02903

Spruce Study Site, Providence

Unknown

Spruce study site, Brisbane

Spruce Study Site, Elizabeth Vale

Spruce Study Site, Melbourne

Spruce Study Site, Brasília

Spruce Study Site, São Paulo

Spruce Study Site, St. John's

Spruce Study Site, London

Spruce Study Site, Aarhus

Spruce Study Site, Copenhagen

Spruce Study Site, Tallinn

Spruce Study Site, Tartu

Spruce Study Site, Munich

Spruce Study Site, Dublin

Spruce Study Site, Milan

Spruce Study Site, Napoli

Spruce Study Site, Rome

Spruce Study Site, Torino

Spruce Study Site, Riga

Spruce Study Site, Kaunas

Spruce Study Site, Nijmegen

Spruce Study Site, Krakow

Spruce Study Site, Warsaw

Spruce Study Site, Bucharest

Spruce Study Site, Seoul

Spruce Study Site, Barcelona

Spruce Study Site, Madrid

Spruce Study Site, Seville

Spruce Study Site, Tarragona

Spruce Study Site, Falun

Spruce Study Site, Stockholm

Spruce Study Site, Sankt Gallen

Spruce Study Site, Zurich

Spruce Study Site, Istanbul

Spruce Study Site, Birmingham

K1H7W9

Spruce Study Site, Ottawa

J1H 5N4

Spruce Study Site, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Spruce Biosciences

INDUSTRY

NCT04457336 - A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH | Biotech Hunter | Biotech Hunter